Cargando…
Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosa (RDEB) is a genodermatosis that leads to skin fragility and chronic wound formation. Patients with RDEB are at risk for cutaneous squamous cell carcinoma (SCC) which is a major cause of morbidity and mortality in these patients. No standard of care exists f...
Autores principales: | Khaddour, Karam, Gorell, Emily S., Dehdashti, Farrokh, Tang, Jean Y., Ansstas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443658/ https://www.ncbi.nlm.nih.gov/pubmed/32884539 http://dx.doi.org/10.1159/000508933 |
Ejemplares similares
-
A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa
por: Tang, Jean Yuh, et al.
Publicado: (2021) -
Squamous cell carcinoma in a pregnant woman with recessive dystrophic epidermolysis bullosa
por: Lopes, Jorge, et al.
Publicado: (2020) -
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa
por: So, Jodi Y., et al.
Publicado: (2022) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018) -
Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa
por: Jeon, In Kyung, et al.
Publicado: (2016)